Skip Navigation

Vaccine Safety Bibliography - July 2011

1.   Interim results: state-specific influenza vaccination coverage --- United States, august 2010--february 2011. MMWR Morb Mortal Wkly Rep. 2011 Jun 10; 60(22):737-43.

2.   Place of influenza vaccination among adults --- United States, 2010--11 influenza season. MMWR Morb Mortal Wkly Rep. 2011 Jun 17; 60(23):781-5.

3.   Vaccines against tick-borne encephalitis: WHO position paper. Wkly Epidemiol Rec. 2011 Jun 10; 86(24):241-56.

4.   Aase A, Herstad TK, Merino S, Bolstad M, Sandbu S, Bakke H, Aaberge IS. Immunization with a fifth dose of reduced dTap-IPV to teenagers induces high levels of pertussis antibodies with a significant increase in opsonophagocytic activity. Clin Vaccine Immunol. 2011 Jun 15. [Epub ahead of print].

5.   Andrews N, Stowe J, Miller E, Svanström H, Johansen K, Bonhoeffer J, Hviid A; for the VAESCO consortium. A collaborative approach to investigating the risk of thrombocytopenic purpura after measles-mumps-rubella vaccination in England and Denmark. Vaccine. 2011 Jun 20. [Epub ahead of print].

6.   Arya SC, Agarwal N. Regarding "type 2 vaccine-derived poliovirus from patients with acute flaccid paralysis in china: current immunization strategy effectively prevented its sustained transmission". J Infect Dis. 2011 Jun; 203(12):1875.

7.   Auriel E, Regev K, Dori A, Karni A. Safety of influenza and H1N1 vaccinations in patients with myasthenia gravis, and patient compliance. Muscle Nerve. 2011 Jun; 43(6):893-4.

8.   Ball R, Botsis T. Can Network Analysis Improve Pattern Recognition Among Adverse Events Following Immunization Reported to VAERS? Clin Pharmacol Ther. 2011 Jun 15. [Epub ahead of print].

9.   Beaulieu AA, Boggild AK. Enteric fever in two vaccinated travellers to Latin America. CMAJ. 2011 Jun 20. [Epub ahead of print].

10.  Bouts A, Monnens L, Davin JC, Struijk G, Spanjaard L. Insufficient protection by Neisseria meningitidis vaccination alone during eculizumab therapy. Pediatr Nephrol. 2011 Jun 5. [Epub ahead of print].

11.  Brown VL, Jane White KA. The role of optimal control in assessing the most cost- effective implementation of a vaccination programme: HPV as a case study. Math Biosci. 2011 Jun; 231(2):126-34.

12.  Cadena J, Prigmore T, Bowling J, Ayala BA, Kirkman L, Parekh A, Scepanski T, Patterson JE. Improving influenza vaccination of healthcare workers by means of quality improvement tools. Infect Control Hosp Epidemiol. 2011 Jun; 32(6):616-8.

13.  Caillet C, Durrieu G, Jacquet A, Faucher A, Ouaret S, Perrault-Pochat MC, Kreft-Jaïs C, Castot A, Montastruc JL; The French Network of Pharmacovigilance Centres. Safety surveillance of influenza A(H1N1)v monovalent vaccines during the 2009-2010 mass vaccination campaign in France. Eur J Clin Pharmacol. 2011 Jun; 67(6):649-651.                                                                                         

14.  Cheffins T, Spillman M, Larkins S, Heal C. Recommending vaccination - General practice intervention with new parents. Aust Fam Physician. 2011 Jun; 40(6):437-9.

15.  Chen JF, Chiang CP, Chen YF, Wang WM. Pityriasis rosea following influenza (H1N1) vaccination. J Chin Med Assoc. 2011 Jun; 74(6):280-2.

16.  Christie J. Interventions to increase influenza vaccination rates of those 60 years and older in the community. Int J Evid Based Healthc. 2011 Jun; 9(2):189-90.

17.  Clarke MF, Davidson GP, Gold MS, Marshall HS. Direct and indirect impact on rotavirus positive and all-cause gastroenteritis hospitalisations in South Australian children following the introduction of rotavirus vaccination. Vaccine. 2011 Jun 24; 29(29-30):4663-7.

18.  Crespo I, Cardeñosa N, Godoy P, Carmona G, Sala MR, Barrabeig I, Alvarez J, Minguel S, Camps N, Caylà J, Batalla J, Codina G, Domínguez A. Epidemiology of pertussis in a country with high vaccination coverage. Vaccine. 2011 Jun 6; 29(25):4244-8.

19.  Das P. Helen Rees on the quest for global equity. Lancet. 2011 Jun 11; 377(9782):1997.

20.  Dauvilliers Y. [Vaccination anti-H1N1 and narcolepsy.]. Rev Neurol (Paris). 2011 Jun 15. [Epub ahead of print].

21.  Dawson A. The moral case for the routine vaccination of children in developed and developing countries. Health Aff (Millwood). 2011 Jun; 30(6):1029-33.

22.  de Whalley PC, Snape MD, Kelly DF, Banner C, Lewis S, Diggle L, John TM, Yu LM, Omar O, Borkowski A, Pollard AJ. Persistence of Serum Bactericidal Antibody One Year After a Booster Dose of Either a Glycoconjugate or a Plain Polysaccharide Vaccine Against Serogroup C Neisseria meningitidis Given to Adolescents Previously Immunized With a Glycoconjugate Vaccine. Pediatr Infect Dis J. 2011 Jun 13. [Epub ahead of print].

23.  den Elzen WP, Vossen AC, Cools HJ, Westendorp RG, Kroes AC, Gussekloo J. Cytomegalovirus infection and responsiveness to influenza vaccination in elderly residents of long-term care facilities. Vaccine. 2011 Jun 24; 29(29-30):4869-74.

24.  Ding H, Santibanez TA, Jamieson DJ, Weinbaum CM, Euler GL, Grohskopf LA, Lu PJ, Singleton JA. Influenza vaccination coverage among pregnant women-National 2009 H1N1 Flu Survey (NHFS). Am J Obstet Gynecol. 2011 Jun; 204(6 Suppl 1):S96-106.

25.  Donnini I, Scappini B, Guidi S, Longo G, Bosi A. Acquired severe aplastic anemia after H1N1 influenza virus vaccination successfully treated with allogeneic bone marrow transplantation. Ann Hematol. 2011 Jun 17. [Epub ahead of print].

26.  Ehrenstein B. [Vaccination prior to travelling for patients with rheumatic diseases.]. Z Rheumatol. 2011 Jun; 70(4):292-298.

27.  Farez MF, Correale J. Yellow Fever Vaccination and Increased Relapse Rate in Travelers With Multiple Sclerosis. Arch Neurol. 2011 Jun 13. [Epub ahead of print].

28.  Feng Z, Towers S, Yang Y. Modeling the Effects of Vaccination and Treatment on Pandemic Influenza. AAPS J. 2011 Jun 8. [Epub ahead of print].

29.  Fernbach A. Parental rights and decision making regarding vaccinations: Ethical dilemmas for the primary care provider. J Am Acad Nurse Pract. 2011 Jul; 23(7):336-45.

30.  Ferreira O, Antunes I, Cruz MJ, Mota A, Bettencourt H, Canelhas A, Azevedo F. Acute hemorrhagic edema of childhood after H1N1 immunization. Cutan Ocul Toxicol. 2011 Jun; 30(2):167-9.

31.  Fleming JD, Fogo AJ, Creamer DJ. Stevens-Johnson syndrome triggered by seasonal influenza vaccination and flucloxacillin: a pathogenetic hypothesis. Eur J Dermatol. 2011 Jun 16. [Epub ahead of print].

32.  Flicker S, Gadermaier E, Madritsch C, Valenta R. Passive Immunization with Allergen-Specific Antibodies. Curr Top Microbiol Immunol. 2011 Jun 18. [Epub ahead of print].

33.  Freund R, Le Ray C, Charlier C, Avenell C, Truster V, Tréluyer JM, Skalli D, Ville Y, Goffinet F, Launay O; for the Inserm COFLUPREG Study Group. Determinants of Non-Vaccination against Pandemic 2009 H1N1 Influenza in Pregnant Women: A Prospective Cohort Study. PLoS One. 2011; 6(6):e20900.

34.  Fridman D, Steinberg E, Azhar E, Weedon J, Wilson TE, Minkoff H. Predictors of H1N1 vaccination in pregnancy. Am J Obstet Gynecol. 2011 Jun; 204(6 Suppl 1):S124-7.

35.  Frühwein M, Frühwein N. [Vaccination for adults in daily use]. MMW Fortschr Med. 2011 Jun 9; 153(23):33-6.

36.  Fujiwara H, Suzuki M, Yoshinari T, Shiiya K. Free school-based vaccination with HPV vaccine in a Japanese city. Vaccine. 2011 Jun 22. [Epub ahead of print].

37.  Garattini L, Padula A. To model or not to model: lessons from two vaccinations. Eur J Health Econ. 2011 Jun; 12(3):189-91.

38.  Gentile A, Bakir J, Firpo V, Caruso M, Lución MF, Abate HJ, Chiossone A, Debbag R. [Delayed vaccine schedule and missed opportunities for vaccination in children up to 24 months: A multicenter study.]. Arch Argent Pediatr. 2011 Jun; 109(3):219-225.

39.  Gertig DM, Brotherton JM, Saville M. Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia. Sex Health. 2011 Jun; 8(2):171-8.

40.  Glaser MS, Chui S, Webber MP, Gustave J, Lee R, McLaughlin MT, Ortiz V, Prezant D, Kelly K. Predictors of acceptance of H1N1 influenza vaccination by FDNY firefighters and EMS workers. Vaccine. 2011 Jun 18. [Epub ahead of print].

41.  Goldfarb I, Panda B, Wylie B, Riley L. Uptake of influenza vaccine in pregnant women during the 2009 H1N1 influenza pandemic. Am J Obstet Gynecol. 2011 Jun; 204(6 Suppl 1):S112-5.

42.  Gottvall M, Tydén T, Larsson M, Stenhammar C, Höglund AT. Challenges and opportunities of a new HPV immunization program Perceptions among Swedish school nurses. Vaccine. 2011 Jun 20; 29(28):4576-83.

43.  Greenberg HB. Rotavirus vaccination and intussusception--act two. N Engl J Med. 2011 Jun 16; 364(24):2354-5.

44.  Grimaldi-Bensouda L, Alpérovitch A, Besson G, Vial C, Cuisset JM, Papeix C, Lyon-Caen O, Benichou J, Rossignol M; Lucien Abenhaim for the GBS-PGRx Study Group. Guillain-Barre Syndrome, Influenzalike Illnesses, and Influenza Vaccination During Seasons With and Without Circulating A/H1N1 Viruses. Am J Epidemiol. 2011 Jun 7. [Epub ahead of print].

45.  Haba-Rubio J, Rossetti AO, Tafti M, Heinzer R. [Narcolepsy with cataplexy associated with H1N1 vaccination.]. Rev Neurol (Paris). 2011 Jun 13. [Epub ahead of print].

46.  Hakim H, Gaur AH, McCullers JA. Motivating factors for high rates of influenza vaccination among healthcare workers. Vaccine. 2011 Jun 20. [Epub ahead of print].

47.  Hanquet G, Ducoffre G, Vergison A, Neels P, Sabbe M, Van Damme P, Van Herck K. Impact of rotavirus vaccination on laboratory confirmed cases in Belgium. Vaccine. 2011 Jun 24; 29(29-30):4698-703.

48.  Har-Even R, Aichenbaum S, Rabey JM, Livne A, Bistritzer T. Measles-vaccinated Israeli boy with subacute sclerosing panencephalitis. Pediatr Neurol. 2011 Jun; 44(6):467-70.

49.  Harder M, Christensson K, Coyne I, Söderbäck M. Five-year-old children's tuning-in and negotiation strategies in an immunization situation. Qual Health Res. 2011 Jun; 21(6):818-29.

50.  Hendrikx LH, de Rond LG, Oztürk K, Veenhoven RH, Sanders EA, Berbers GA, Buisman AM. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age. Vaccine. 2011 Jun 12. [Epub ahead of print].

51.  Henrich NJ. Increasing pandemic vaccination rates with effective communication. Hum Vaccin. 2011 Jun 1;7(6). [Epub ahead of print].

52.  Heyman KP, Worley MJ Jr, Frey MK, Kessler RT, Bodurka DC, Slomovitz BM. Willingness of pregnant women to vaccinate themselves and their newborns with the HPV vaccine. Vaccine. 2011 Jun 20; 29(28):4618-22.

53.  Holmlund E, Nohynek H, Quiambao B, Ollgren J, Käyhty H. Mother-infant vaccination with pneumococcal polysaccharide vaccine: Persistence of maternal antibodies and responses of infants to vaccination. Vaccine. 2011 Jun 20; 29(28):4565-75.

54.  Holtfreter S, Jursa-Kulesza J, Masiuk H, Verkaik NJ, de Vogel C, Kolata J, Nowosiad M, Steil L, van Wamel W, van Belkum A, Völker U, Giedrys-Kalemba S, Bröker BM. Antibody responses in furunculosis patients vaccinated with autologous formalin-killed Staphylococcus aureus. Eur J Clin Microbiol Infect Dis. 2011 Jun; 30(6):707-17.

55.  Huber BM, Goetschel P. Extensive limb swelling after vaccination. J Pediatr. 2011 Jun; 158(6):1033.

56.  Jackson LA, Peterson D, Dunn J, Hambidge SJ, Dunstan M, Starkovich P, Yu O, Benoit J, Dominguez-Islas CP, Carste B, Benson P, Nelson JC. A randomized placebo-controlled trial of acetaminophen for prevention of post-vaccination Fever in infants. PLoS One. 2011; 6(6):e20102.

57.  Jhanji V, Naithani P, Lamoureux E, Agarwal T, Sharma N, Vajpayee RB. Immunization and nutritional profile of cases with atraumatic microbial keratitis in preschool age group. Am J Ophthalmol. 2011 Jun; 151(6):1035-1040.e2.

58.  Johnson PL, Kochin BF, McAfee MS, Stromnes IM, Regoes RR, Ahmed R, Blattman JN, Antia R. Vaccination alters the balance between protective immunity, exhaustion, escape, and death in chronic infections. J Virol. 2011 Jun; 85(11):5565-70.

59.  Johnston SB. Should males be vaccinated against HPV? Nursing. 2011 Jun; 41(6):62-3.

60.  Kaiser HE, Barnett DJ, Hayanga AJ, Brown ME, Filak AT. Medical Students' Participation in the 2009 Novel H1N1 Influenza Vaccination Administration: Policy Alternatives for Effective Student Utilization to Enhance Surge Capacity in Disasters. Disaster Med Public Health Prep. 2011 Jun; 5(2):150-153.

61.  Katerinis I, Hadaya K, Duquesnoy R, Ferrari-Lacraz S, Meier S, van Delden C,  Martin PY, Siegrist CA, Villard J. De Novo Anti-HLA Antibody After Pandemic H1N1 and Seasonal Influenza Immunization in Kidney Transplant Recipients. Am J Transplant. 2011 Jun 14. [Epub ahead of print].

62.  Klooster TM, Kemmeren JM, van der Maas NA, de Melker HE. Reported adverse events in girls aged 13-16 years after vaccination with the human papillomavirus (HPV)-16/18 vaccine in the Netherlands. Vaccine. 2011 Jun 20; 29(28):4601-7.

63.  Kumar D, Danziger-Isakov L. Immunization Against Influenza: A Balancing Act.  Am J Transplant. 2011 Jun 14. [Epub ahead of print].

64.  Lang DP. Inactivated influenza vaccines:: pre-vaccination haemagglutinin-antibody titres influence the vaccine response but not necessarily the vaccine effectiveness. Drugs Aging. 2011 Jun 1; 28(6):505.

65.  Larsson HE, Lernmark A. Vaccination against type 1 diabetes. J Intern Med. 2011 Jun; 269(6):626-35.

66.  Laxminarayan R, Ganguly NK. India's Vaccine Deficit: Why More Than Half Of Indian Children Are Not Fully Immunized, And What Can--And Should--Be Done. Health Aff (Millwood). 2011 Jun; 30(6):1096-103.

67.  Lefevere E, Hens N, De Smet F, Van Damme P. Dynamics of HPV vaccination initiation in Flanders (Belgium) 2007-2009: a Cox regression model. BMC Public Health. 2011 Jun 14; 11:470.

68.  Litton AG, Desmond RA, Gilliland J, Huh WK, Franklin FA. Factors Associated with Intention to Vaccinate a Daughter against HPV: A Statewide Survey in Alabama. J Pediatr Adolesc Gynecol. 2011 Jun; 24(3):166-71.

69.  Martínez Romero M, Martínez Diz S, García Iglesias F. [Why don't parents vaccinate their children? Reflections on a measles outbreak in a neighbourhood of Granada.]. An Pediatr (Barc). 2011 Jun 13. [Epub ahead of print].

70.  Maurer J, Harris KM. Contact and communication with healthcare providers regarding influenza vaccination during the 2009-2010 H1N1 pandemic. Prev Med. 2011 Jun 1; 52(6):459-64.

71.  McQuestion M, Gnawali D, Kamara C, Kizza D, Mambu-Ma-Disu H, Mbwangue J, de Quadros C. Creating sustainable financing and support for immunization programs in fifteen developing countries. Health Aff (Millwood). 2011 Jun; 30(6):1134-40.

72.  Milkman KL, Beshears J, Choi JJ, Laibson D, Madrian BC. Using implementation intentions prompts to enhance influenza vaccination rates. Proc Natl Acad Sci U S A. 2011 Jun 28; 108(26):10415-20.

73.  Morano R, Pérez F, Brosa M, Escolano IP. [Cost-effectiveness analysis of pneumococcal vaccination in Spain.]. Gac Sanit. 2011 Jun 1. [Epub ahead of print].

74.  Moszynski P. London vaccination summit offers "unprecedented opportunity to save millions of lives". BMJ. 2011 Jun 6; 342:d3556.

75.  Moszynski P. London vaccination summit is "milestone in global health". BMJ.  2011 Jun 14; 342:d3766.

76.  Myers ER, Misurski DA, Swamy GK. Influence of timing of seasonal influenza vaccination on effectiveness and cost-effectiveness in pregnancy. Am J Obstet Gynecol. 2011 Jun; 204(6 Suppl 1):S128-40.

77.  Nates SV, Frias M, Belfiore S, Isa MB, Martinez LC, Chuit R, Armoni J, Luxemburger C. Effect on seroprevalence of anti-poliovirus antibodies and on vaccination coverage of the implementation of a DTwP-IPV-Hib vaccination programme in a South American city. Epidemiol Infect. 2011 Jun; 139(6):826-35.

78.  Nelson CB, de Quadros C. Coalition against typhoid: A new, global initiative to advance typhoid vaccination. Vaccine. 2011 Jun 20. [Epub ahead of print].

79.  Olufowote JO. Local Resistance to the Global Eradication of Polio: Newspaper Coverage of the 2003-2004 Vaccination Stoppage in Northern Nigeria. Health Commun. 2011 Jun 10:1-11. [Epub ahead of print].

80.  Park B, Lee YK, Cho LY, Go UY, Yang JJ, Ma SH, Choi BY, Lee MS, Lee JS, Choi EH, Lee HJ, Park SK. Estimation of nationwide vaccination coverage and comparison of interview and telephone survey methodology for estimating vaccination status. J Korean Med Sci. 2011 Jun; 26(6):711-9.

81.  Patel MM, López-Collada VR, Bulhões MM, De Oliveira LH, Bautista Márquez A, Flannery B, Esparza-Aguilar M, Montenegro Renoiner EI, Luna-Cruz ME, Sato HK, Hernández-Hernández Ldel C, Toledo-Cortina G, Cerón-Rodríguez M, Osnaya-Romero N, Martínez-Alcazar M, Aguinaga-Villasenor RG, Plascencia-Hernández A, Fojaco-González F, Hernández-Peredo Rezk G, Gutierrez-Ramírez SF, Dorame-Castillo R, Tinajero-Pizano R, Mercado-Villegas B, Barbosa MR, Maluf EM, Ferreira LB, de Carvalho FM, dos Santos AR, Cesar ED, de Oliveira ME, Silva CL, de Los Angeles Cortes M, Ruiz Matus C, Tate J, Gargiullo P, Parashar UD. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med.  2011 Jun 16; 364(24):2283-92.

82.  Payne DC, Staat MA, Edwards KM, Szilagyi PG, Weinberg GA, Hall CB, Chappell J, Curns AT, Wikswo M, Tate JE, Lopman BA, Parashar UD; the New Vaccine Surveillance Network (NVSN). Direct and Indirect Effects of Rotavirus Vaccination Upon Childhood Hospitalizations in 3 US Counties, 2006-2009. Clin Infect Dis. 2011 Jun 23. [Epub ahead of print].

83.  Pereira LA, Raboni SM, Nogueira MB, Vidal LR, Almeida SM, Debur MC, Cruz C. Rotavirus infection in a tertiary hospital: laboratory diagnosis and impact of immunization on pediatric hospitalization. Braz J Infect Dis. 2011 Jun; 15(3):215-9.

84.  Petersen KD, Kronborg C, Gyrd-Hansen D, Dahl R, Larsen JN, Linneberg A. Characteristics of patients receiving allergy vaccination: to which extent do socio-economic factors play a role? Eur J Public Health. 2011 Jun; 21(3):323-8.

85.  Picazo J, Ruiz-Contreras J, Casado-Flores J, Negreira S, Del Castillo F, Hernández-Sampelayo T, Bueno M, Calvo C, Ríos E, Méndez C; on Behalf of the HERACLES Study Group. Laboratory-based, 2-year Surveillance of Pediatric Parapneumonic Pneumococcal Empyema Following Heptavalent Pneumococcal Conjugate Vaccine Universal Vaccination in Madrid. Pediatr Infect Dis J. 2011 Jun; 30(6):471-474.

86.  Pierson DL, Mehta SK, Gilden D, Cohrs RJ, Nagel MA, Schmid DS, Tyring SK. Varicella zoster virus DNA at inoculation sites and in saliva after zostavax immunization. J Infect Dis. 2011 Jun; 203(11):1542-5.

87.  Poehling KA, Szilagyi PG, Staat MA, Snively BM, Payne DC, Bridges CB, Chu SY, Light LS, Prill MM, Finelli L, Griffin MR, Edwards KM; New Vaccine Surveillance Network. Impact of maternal immunization on influenza hospitalizations in infants. Am J Obstet Gynecol. 2011 Jun; 204(6 Suppl 1):S141-8.

88.  Pulendran B, Ahmed R. Immunological mechanisms of vaccination. Nat Immunol. 2011 Jun; 131(6):509-17.

89.  Rodríguez-Rieiro C, Hernández-Barrera V, Carrasco-Garrido P, de Andres AL, Jiménez-García R. Vaccination against 2008/2009 and 2009/2010 seasonal influenza in Spain: Coverage among high risk subjects, HCWs, immigrants and time trends from the 2005/2006 campaign. Vaccine. 2011 Jun 22. [Epub ahead of print].

90.  Roehr B. Economic benefits of vaccination need to be seen in wider context. BMJ. 2011 Jun 14; 342:d3721.

91.  Roggendorf H, Sprave T, Hertel S, Morscheck F, Roggendorf M. [Rate of influenza vaccination among medical staff working at a university hospital.]. Dtsch Med Wochenschr. 2011 Jun; 136(24):1299-1304.

92.  Rozenbaum MH, Mangen MJ, Giaquinto C, Wilschut JC, Hak E, Postma MJ, Corova-Group CG. Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model. BMC Public Health. 2011 Jun 10; 11(1):462. [Epub ahead of print].

93.  Ruijs WL, Hautvast JL, van Ansem WJ, Akkermans RP, Van't Spijker K, Hulscher ME, van der Velden K. Measuring vaccination coverage in a hard to reach minority. Eur J Public Health. 2011 Jun 29. [Epub ahead of print].

94.  Ruijs WL, Hautvast JL, van 't Spijker K, van der Velden K, Hulscher ME. Information on vaccination: meeting the needs of unvaccinated youngsters in the Netherlands. Eur J Public Health. 2011 Jun; 21(3):344-6.

95.  Sabarwal S, McCormick MC, Silverman JG, Subramanian SV. Association Between Maternal Intimate Partner Violence Victimization and Childhood Immunization in India. J Trop Pediatr. 2011 Jun 24. [Epub ahead of print].

96.  Schatz M, Chambers CD, Jones KL, Louik C, Mitchell AA. Safety of influenza immunizations and treatment during pregnancy: the Vaccines and Medications in Pregnancy Surveillance System. Am J Obstet Gynecol. 2011 Jun; 204(6 Suppl 1):S64-8.

97.  Schleiss MR. Could therapeutic vaccination of cytomegalovirus-seropositive persons prevent reinfection and congenital virus transmission? J Infect Dis. 2011 Jun; 203(11):1513-6.

98.  Schuurmans MM, Tini GM, Dalar L, Fretz G, Benden C, Boehler A. Pandemic 2009 H1N1 influenza virus vaccination in lung transplant recipients: coverage, safety and clinical effectiveness in the Zurich cohort. J Heart Lung Transplant. 2011 Jun; 30(6):685-90.

99.  Scriba TJ, Tameris M, Mansoor N, Smit E, van der Merwe L, Mauff K, Hughes EJ, Moyo S, Brittain N, Lawrie A, Mulenga H, de Kock M, Gelderbloem S, Veldsman A, Hatherill M, Geldenhuys H, Hill AV, Hussey GD, Mahomed H, Hanekom WA, McShane H. Dose-Finding Study of the Novel Tuberculosis Vaccine, MVA85A, in Healthy BCG-Vaccinated Infants. J Infect Dis. 2011 Jun; 203(12):1832-43.

100. Skiles MP, Cai J, English A, Ford CA. Retail pharmacies and adolescent vaccination-an exploration of current issues. J Adolesc Health. 2011 Jun; 48(6):630-2.

101. Smit PM, Veldhuis S, Mulder JW, Roggeveen C, Rimmelzwaan GF, Meijers JC, Beijnen JH, Brandjes DP. Influenza vaccination and hemostasis: no sustainable procoagulant effects from 2009 H1N1 influenza vaccine in healthy healthcare workers. J Thromb Haemost. 2011 Jun 22.  [Epub ahead of print].

102. Steelfisher GK, Blendon RJ, Bekheit MM, Mitchell EW, Williams J, Lubell K, Peugh J, DiSogra CA. Novel pandemic A (H1N1) influenza vaccination among pregnant women: motivators and barriers. Am J Obstet Gynecol. 2011 Jun; 204(6 Suppl 1):S116-23.

103. Stockwell MS, Rosenthal SL, Sturm LA, Mays RM, Bair RM, Zimet GD. The effects of vaccine characteristics on adult women's attitudes about vaccination: A conjoint analysis study. Vaccine. 2011 Jun 15; 29(27):4507-11.

104. Stokley S, Vogt T, Shefer A. Increasing adolescent vaccination coverage: the challenges that remain. Arch Pediatr Adolesc Med. 2011 Jun; 165(6):568-70.

105. Sulsky SI, Luippold RS, Garman P, Hughes H, Amoroso PJ. Risk of disability for US army personnel vaccinated against anthrax, 1998-2005. Vaccine. 2011 Jun 22. [Epub ahead of print].

106. Sunil TS, Zottarelli LK. Student utilization of a university 2009 H1N1 vaccination clinic. Vaccine. 2011 Jun 24; 29(29-30):4687-9.

107. Sutherland JN, Chang C, Yoder SM, Rock MT, Maynard JA. Antibodies Recognizing Protective Pertussis Toxin Epitopes Are Preferentially Elicited by Natural Infection versus Acellular Immunization. Clin Vaccine Immunol. 2011 Jun; 18(6):954-62.

108. Szilagyi PG, Humiston SG, Gallivan S, Albertin C, Sandler M, Blumkin A. Effectiveness of a citywide patient immunization navigator program on improving adolescent immunizations and preventive care visit rates. Arch Pediatr Adolesc Med. 2011 Jun; 165(6):547-53.

109. Tanguy M, Boyeau C, Pean S, Marijon E, Delhumeau A, Fanello S. Acceptance of seasonal and pandemic a (H1N1) 2009 influenza vaccination by healthcare workers in a French Teaching Hospital. Vaccine. 2011 Jun 6; 29(25):4190-4.

110. Thapa SD, Koirala KD. Vaccination against meningococcal meningitis outside the meningitis belt. Lancet Infect Dis. 2011 Jun; 11(6):427.

111. Toback SL, Herley J, Edelman L, Ambrose CS. Trends in US pediatric influenza vaccination from 2006 to 2010 among children with private insurance. Vaccine. 2011 Jun 6; 29(25):4225-9.

112. Tregnaghi MW, Abate HJ, Valencia A, Lopez P, Da Silveira TR, Rivera L, Rivera Medina DM, Saez-Llorens X, Gonzalez Ayala SE, De León T, Van Doorn LJ, Pilar Rubio MD, Suryakiran PV, Casellas JM, Ortega-Barria E, Smolenov IV, Han HH; the Rota-024 Study Group. Human Rotavirus Vaccine Is Highly Efficacious When Coadministered With Routine Expanded Program of Immunization Vaccines Including Oral Poliovirus Vaccine in Latin America. Pediatr Infect Dis J. 2011 Jun; 30(6):e103-e108.

113. Tuppin P, Samson S, Weill A, Ricordeau P, Allemand H. Seasonal influenza vaccination coverage in France during two influenza seasons (2007 and 2008) and during a context of pandemic influenza A(H1N1) in 2009. Vaccine. 2011 Jun 20; 29(28):4632-7.

114. Visser LG. TNF-α Antagonists and Immunization. Curr Infect Dis Rep. 2011 Jun; 13(3):243-7.

115. von Spiczak S, Helbig I, Drechsel-Baeuerle U, Muhle H, van Baalen A, van Kempen MJ, Lindhout D, Scheffer IE, Berkovic SF, Stephani U, Keller-Stanislawski B. A retrospective population-based study on seizures related to childhood vaccination. Epilepsia. 2011 Jun 21. [Epub ahead of print].

116. Waters O, Ahmad T. Opportunistic infections and vaccinations in IBD patients. J Crohns Colitis. 2011 Jun; 5(3):263.

117. Wicker S, Rabenau HF, Ackermann H, Poland GA, Marckmann G. [Does patient safety justify mandatory vaccinations?]. Dtsch Med Wochenschr. 2011 Jun; 136(24):1305-1311.

118. Wing JB, Smart L, Borrow R, Findlow J, Findlow H, Heath AW, Read RC. Kinetics of immune responses to nasal challenge with meningococcal polysaccharide one year after serogroup-C glycoconjugate vaccination. Clin Infect Dis. 2011 Jun; 52(11):1317-23.

119. Wood N, Siegrist CA. Neonatal immunization: where do we stand? Curr Opin Infect Dis. 2011 Jun; 24(3):190-5.

120. Wu B, Fu F, Wang L. Imperfect vaccine aggravates the long-standing dilemma of voluntary vaccination. PLoS One. 2011; 6(6):e20577.

121. Zipursky S, Boualam L, Cheikh DO, Fournier-Caruana J, Hamid D, Janssen M, Kartoglu U, Waeterloos G, Ronveaux O. Assessing the potency of oral polio vaccine kept outside of the cold chain during a national immunization campaign in Chad. Vaccine. 2011 Jun 20. [Epub ahead of print].